Fig. 1: Workflow of this study. | Nature Communications

Fig. 1: Workflow of this study.

From: Synthetic hydrogel nanoparticles for sepsis therapy

Fig. 1

First, we develop HNPs with PEG modification to optimize their histone affinity, capacity, low-aggregation, and blood circulation time altogether to achieve highly effective sepsis therapy. Next, we evaluate PEGHNPs in vitro. Finally, we evaluate the efficacy of PEGHNPs using living mice in vivo.

Back to article page